Infographics

Novel pharmacological interventions targeting lipids can lower the incidence of dyslipidaemia triggered cardiovascular events. Check out and download our latest infographic providing insights into evolution of lipid-lowering therapeutics and status of novel therapeutics highlighting their development, safety, and efficacy.

First published: August 8, 2022  

Statin therapy is a cornerstone for the prevention and treatment of CVD. However, statin associated muscle symptoms (SAMS) are serious side-effects of statin use and often lead to discontinuation of statin therapy. Check out and download our latest infographic highlighting the challenges, and recommendations for diagnosis and management of SAMS.

First published: May 24, 2022  

To mark the first Lipoprotein (a) awareness day on March 24, 2022, check out and download our latest infographic that highlights the role of Lp (a) in Familial Hypercholesterolaemia and ASCVD.

First published: March 24, 2022  

Check out and download our latest infographics highlighting the important findings of the REDUCE-IT Trials. The multicenter, placebo-controlled, double-blind trial REDUCE-IT assesses the therapeutic effects of icosapent ethyl, a stable eicosapentaenoic acid ethyl ester, in such patients.

First published: December 13, 2021  

This infographic summarizes the key takeaway messages from the recently published National Lipid Association (NLA) Scientific Statement on Lipid Measurements in the Management of Cardiovascular Diseases.

First published: October 21, 2021  

There was a lot to process from the latest ESC guidance on CVD prevention. This infographic focusses on the key updates in ASCVD and lipidology, which revolved around the importance of risk assessment and the best time to initiate treatment.

First published: September 16, 2021